Efficacy and Safety of Nefecon in Patients With Primary IgA (Immunoglobulin A) Nephropathy
Clinical trial NCT03643965 · COMPLETED
Trial details
- NCT number
- NCT03643965
- Sponsor
- Calliditas Therapeutics AB
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-05
- Primary completion
- 2023-07-10
- Enrollment
- 365
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.